Commitments and Contingencies

12 Months Ended

Dec. 31, 2011

Commitments and Contingencies [Abstract]

Commitments and Contingencies

Note 6. Commitments and Contingencies

Total rent expense per year was E174 for 2011 and E194 for 2010. A penalty of E54 has been paid for dropping the option on the additional space planned for a laboratory in Epalinges. The lease of the Company's Nyon, Switzerland facility expired in 2011; the lease of the Company's Lausanne, Switzerland facilities expires in 2016 and the lease of the Company's facilities in Leiden, the Netherlands, can be terminated in 2013.

Future lease payments expected on the above office leases are as follows for the years ending December 31:

Office Rent Expected	2012		2013		2014		2015		2016
LAUSANNE	E	46	E	46	E	46	E	46	E	38
LEIDEN	E	86	E	57	E	--	E	--	E	--
TOTAL	E	132	E	68	E	46	E	46	E	38

As per an agreement signed on December 22, 2008, PX Therapeutics has granted the license rights of the general know-how of Gp41 manufacturing technology to Mymetics for five years. During this period, the Company pays to PX Therapeutics an annual fee of E200 until the expiration date of December 23, 2012.